← Leaderboards
Donald Mahoney
Baylor College Of Medicine
$44,871
Attributed
$44,871
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $31.4K · FY2005–10$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$44,871 · 3
By mechanism
M01$44,871 · 3
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- William Thomas Shearer$34,592,326
- Susan M Blaney$10,519,074
- David G. Poplack$17,817,283
- John William Swann$16,335,577
- Jose Aron Lopez$21,118,772
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAdolescentBuffersAntineoplasticsArea Under CurveBlood Disorder ChemotherapyAdultCharacteristicsChildrenChronic Disease /DisorderClinical LotAdherence (Attribute)Clinical TrialsCohortCommunitiesComputer Retrieval Of Information On Scientific Projects DatabaseCross-Over StudiesDoseDrug KineticsDrug Screening /EvaluationElementsEvaluationExcipientsAcute
Grant awards (4)
CLINICAL TRIAL: A PHASE I, PROSPECTIVE, RANDOMIZED, CROSSOVER STUDY TO COMPARE$3,052
M01 · FY2010 · RR · contact PI
TRIAL OF RITUXIMAB FOR CHRONIC, SEVERE IDIOPATHIC THROMBOCYTOPENIC PURPURA$7,444
M01 · FY2006 · RR · contact PI
TRIAL OF RITUXIMAB FOR CHRONIC, SEVERE IDIOPATHIC THROMBOCYTOPENIC PURPURA$31,394
M01 · FY2005 · RR
Rituximab for Chronic, Severe Idiopathic Thrombocytopeni$2,981
M01 · FY2004 · RR